Applications of Spatial Transcriptomics in Immune Tissues

Spatial transcriptomics (ST) has emerged as a transformative technology that bridges the gap between high‑throughput gene‑expression profiling and the spatial context of cells within intact tissues. Traditional bulk RNA‑seq discards positional information, while single‑cell RNA‑seq captures cellular heterogeneity at the expense of tissue architecture. ST preserves the geographic coordinates of each transcript, enabling researchers to map whole‑transcriptome activity directly onto histological sections. This capability is especially powerful in immunology, where the function of immune cells is tightly linked to their location and interactions within organized structures such as lymph nodes, germinal centers, and tumor niches.

Technological Landscape

Sequencing‑Based Platforms

The most widely adopted sequencing‑based approach is exemplified by the 10x Genomics Visium platform. Tissue sections are placed on a slide that contains an array of spatially barcoded capture spots. After permeabilization, released mRNA hybridizes to oligonucleotides bearing a unique barcode that corresponds to its original location. Reverse transcription, library preparation, and next‑generation sequencing generate reads that can be computationally projected back onto the tissue image, producing a transcriptomic map at a resolution of 55–100 µm per spot.

Key advantages

• Unbiased, genome‑wide profiling across the entire tissue section.
• Straightforward integration with existing scRNA‑seq pipelines for cell‑type deconvolution.

Limitations

• Spot size limits single‑cell resolution; each spot may contain transcripts from multiple cells.
• Requires relatively fresh or well‑preserved tissue to maintain RNA integrity.

Imaging‑Based Platforms

Fluorescence in situ hybridization (FISH)–based methods such as CosMx SMI, MERFISH, and Xenium achieve subcellular resolution by iteratively hybridizing fluorescent probes to target RNAs and imaging the signal. Hundreds to thousands of genes can be multiplexed in a single experiment, and the resulting data retain the exact cellular and even subcellular coordinates of each transcript.

Key advantages

• True single‑cell (or subcellular) resolution, allowing precise mapping of cell‑cell contacts.
• High multiplexing depth for targeted panels, ideal for dissecting immune signaling pathways.

Limitations

• Requires prior selection of target genes; not truly genome‑wide.
• More complex instrumentation and data‑analysis pipelines.

Together, these two strategies provide complementary tools: sequencing‑based ST for exploratory, unbiased surveys, and imaging‑based ST for deep, high‑resolution interrogation of predefined gene sets.

Core Spatial Principles in Immune Tissues

1. Compartmentalization

Secondary lymphoid organs are organized into distinct micro‑anatomical compartments (e.g., T‑cell zones, B‑cell follicles, marginal zones). Spatial transcriptomics can quantify gene‑expression gradients across these regions, revealing how chemokine receptors, adhesion molecules, and transcription factors orchestrate cell migration and residency. For instance, a gradient of CXCL13 in a follicle correlates with the positioning of CXCR5⁺ B cells, while CCL19/21 demarcate T‑cell zones.

2. Juxtacrine Signaling

Effective immune responses often depend on direct cell‑cell contact—antigen presentation, co‑stimulatory signaling, and immune synapse formation. By overlaying spatial expression of ligand–receptor pairs (e.g., CD40–CD40L, PD‑L1–PD‑1) onto tissue maps, researchers can infer which cell populations are likely engaging in juxtacrine communication at a given location. This spatially resolved interactome adds a layer of functional insight that bulk or dissociated single‑cell data cannot provide.

3. Spatiotemporal Dynamics

Immune processes are inherently dynamic. Sequential tissue sections or longitudinal biopsies enable the reconstruction of spatiotemporal trajectories—for example, tracking the influx of neutrophils during acute infection, the subsequent recruitment of monocytes, and the eventual formation of a resolution niche enriched in IL‑10 and TGF‑β. By aligning spatial maps across time points, investigators can visualize the rise, peak, and decline of immune activity in situ.

Innate vs. Adaptive Immunity: A Spatial Dialogue

Spatial transcriptomics has illuminated how these two arms converge at inflammation borders. Innate cells often act as “first responders,” depositing chemokines that sculpt a microenvironment conducive to adaptive cell recruitment. Imaging‑based ST can capture, at single‑cell resolution, the precise points where dendritic cells present antigen to naïve T cells, or where macrophage‑derived IL‑12 aligns with IFN‑γ‑producing NK cells.

Front‑Line Applications

Tumor Immune Microenvironment (TIME)

• Mapping immune heterogeneity: By segmenting a tumor section into core, invasive margin, and adjacent normal tissue, ST reveals distinct transcriptional programs of CD8⁺ cytotoxic T cells, regulatory T cells, and tumor‑associated macrophages.
• Predicting therapy response: Spatial co‑localization of PD‑L1⁺ tumor cells with PD‑1⁺ exhausted T cells has been linked to better responses to checkpoint blockade, while exclusion of T cells from the tumor core often predicts resistance.
• Identifying resistance niches: ST can pinpoint regions enriched for β‑catenin signaling or TGF‑β that foster immune evasion, guiding combination‑therapy strategies.

Autoimmune Diseases

• Ectopic lymphoid structures: In rheumatoid arthritis synovium or lupus nephritis, ST delineates tertiary lymphoid structures (TLS), showing spatially restricted expression of CXCL13, LTβR, and AID, which drive local autoantibody production.
• Target discovery: By comparing inflamed versus quiescent zones, researchers have uncovered region‑specific upregulation of JAK‑STAT pathway genes, informing targeted inhibition.

Infectious and Host‑Defense Studies

• Viral tropism: Spatial profiling of infected lung tissue can map viral RNA alongside host interferon‑stimulated genes, revealing hotspots of viral replication versus areas of effective antiviral signaling.
• Bacterial biofilm interactions: In chronic wound models, ST distinguishes bacterial colonies from surrounding immune infiltrates, highlighting gradients of IL‑1β and TNF‑α that shape tissue repair.

Future Directions and Outlook

1. Multi‑modal integration – Combining ST with spatial proteomics (e.g., CODEX, IMC) and high‑resolution imaging will provide a truly multi‑omics view of immune niches, linking transcripts to protein activity and post‑translational modifications.

2. Higher resolution and throughput – Ongoing advances in microfluidic capture arrays and iterative FISH chemistries aim to bring single‑molecule resolution to whole‑tissue sections without sacrificing genome‑wide coverage.

3. Computational frameworks – Robust algorithms for cell‑type deconvolution, spatial ligand‑receptor inference, and trajectory reconstruction are essential to translate raw spot‑level data into biologically actionable maps.

4. Clinical translation – As costs decline, ST is poised to become a routine diagnostic adjunct in pathology labs, guiding immunotherapy decisions, monitoring disease activity in autoimmunity, and assessing vaccine‑induced tissue responses.

Conclusion

Spatial transcriptomics has fundamentally reshaped our ability to study immune tissues. By preserving the spatial coordinates of gene expression, it reveals how compartmentalization, direct cell‑cell communication, and temporal evolution converge to orchestrate immune defense and homeostasis. Whether dissecting the intricate architecture of a germinal center, unraveling the suppressive niches within a tumor, or charting the wave of immune cells that combat an infection, ST provides an unprecedented panoramic view. As technologies mature and become more accessible, spatial transcriptomics will undoubtedly become a cornerstone of both basic immunology research and precision medicine.